Hong Kong at a glance
- Population
- 7.5 million 2025
- Life expectancy at birth
- 85.4 years, 2024
- People aged 65 and over
- 23.7 % of people, 2025
Updated
Reviewed by Vidhi Upadhyay
Hong Kong Menopause Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$6.6 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $5.7 Mn | — | — |
| 2025 (base) | $6.2 Mn | +$0.5 Mn | — |
| 2026 (forecast) | $6.8 Mn | +$0.5 Mn | +8.4% |
| 2027 (forecast) | $7.3 Mn | +$0.6 Mn | +17.5% |
| 2028 (forecast) | $7.9 Mn | +$0.6 Mn | +27.4% |
| 2029 (forecast) | $8.6 Mn | +$0.7 Mn | +38.1% |
| 2030 (forecast) | $9.3 Mn | +$0.7 Mn | +49.7% |
| 2031 (forecast) | $10.1 Mn | +$0.8 Mn | +62.2% |
| 2032 (forecast) | $11.0 Mn | +$0.8 Mn | +75.9% |
| 2033 (forecast) | $11.9 Mn | +$0.9 Mn | +90.6% |
| 2034 (forecast) | $12.9 Mn | +$1.0 Mn | +106.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $6.2 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $12.9 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 8.4% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Ingredient, form and distribution channel (see all) |
| Key players | Bayer AG, Amberen, Bonafide Health, Church & Dwight Co., Inc, Haleon PLC (see all) |
| Regulator in Hong Kong | Drug Office and Centre for Food SafetySource: Drug Office, Department of Health. Checked 14 Nov 2026.Source: Centre for Food Safety. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Menopause supplements contain herbs, vitamins and plant compounds marketed to ease hot flashes, mood changes and bone loss.
Key segments of the menopause Supplements market include ingredient (Black Cohosh, Soy Isoflavones and Vitamin D and Calcium) and form (Capsules, Gummies and Powders).
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the menopause Supplements market. New products designed around women's biology and digital care are improving access.
Femtech, personalised care and new treatments for under-served conditions open strong growth for the menopause Supplements market, especially as employers and payers add women's health benefits.
Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the menopause Supplements market.
The menopause Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Pharmaceutical products must be registered with the Pharmacy and Poisons Board before sale, through the Drug Office of the Department of Health.[1] Health supplements are generally regulated as food, overseen by the Centre for Food Safety; proprietary Chinese medicines must be registered with the Chinese Medicine Council.[2]
[1] Drug Office, Department of Health. Checked 14 Nov 2026.
[2] Centre for Food Safety. Checked 14 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern menopause Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Hong Kong.
What doctors and scientists are doing in Menopause Supplements right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
From our blog
Hong Kong · 5 shared keywords
Hong Kong · 3 shared keywords
Hong Kong · 3 shared keywords
Hong Kong · 3 shared keywords
Hong Kong · 3 shared keywords
Hong Kong · 3 shared keywords
Pharmaceuticals · Hong Kong
Healthcare Services · Hong Kong
Pharmaceuticals · Hong Kong
Medical Devices · Hong Kong
Pharmaceuticals · Hong Kong
Pharmaceuticals · Hong Kong